The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 3, open-label, randomized study of the FLT3 inhibitor gilteritinib versus salvage chemotherapy in adults with first relapse or primary refractory FLT3 mutation-positive acute myeloid leukemia.
 
Alexander E. Perl
Honoraria - Dava Oncology
Consulting or Advisory Role - Actinium Pharmaceuticals; Arog; Asana biosciences; Astellas Pharma; Seagen
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)
 
Stephen Anthony Strickland
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Baxalta; Boehringer Ingelheim; CTI; Daiichi Sankyo; Sunesis Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Celator (Inst); Cyclacel (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Sanofi (Inst); Sunesis Pharmaceuticals (Inst)
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Andreas Neubauer
No Relationships to Disclose
 
Giovanni Martinelli
Consulting or Advisory Role - Amgen; ARIAD; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Tomoki Naoe
Research Funding - Astellas Pharma; Celgene; Dainippon Sumitomo Pharma; Fujifilm; Kyowa Hakko Kirin; Nippon Boehringer Ingelheim; Otsuka; Pfizer; Toyama Chemical Co
Patents, Royalties, Other Intellectual Property - Fujifilm
 
Arnaud Pigneux
No Relationships to Disclose
 
Philippe H. Rousselot
No Relationships to Disclose
 
Christoph Röllig
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Roche; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Novartis; Takeda
Research Funding - Bayer
Travel, Accommodations, Expenses - Amgen; Celgene; Gilead Sciences; Janssen
 
Maria R. Baer
No Relationships to Disclose
 
Richard A. Larson
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst)
 
Angela Joubert James
Employment - Astellas Pharma
Stock and Other Ownership Interests - Celgene
Research Funding - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Celgene
Travel, Accommodations, Expenses - Astellas Pharma
 
Caroline Chen
Employment - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Lei Shu
Employment - Abbvie; Astellas Pharma
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie; Astellas Pharma
 
Nahla Hasabou
Employment - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Erkut Bahceci
Employment - Astellas Pharma